Ireland
--:--IST
Trust & transparency

Editorial Standards & Corrections

Our mission

Priya Life Science is an independent news and intelligence platform covering the pharmaceutical, biotechnology, MedTech and life-science sectors, with a focus on Ireland and Europe. We exist to give professionals, jobseekers and students accurate, timely and useful information - free of charge.

Sourcing

Our reporting is grounded in primary sources: company announcements, regulatory filings and registers (HPRA, EMA, FDA), ClinicalTrials.gov, government and IDA Ireland publications, and on-the-record statements. Our data products - the Irish Medicines Database, Clinical Trials Tracker, Ireland Pharma Map and jobs feed - state their sources and refresh schedules on each page. Where we analyse or estimate, we say so.

How we check every article

Every article goes through the same four steps before it is published:

  1. Primary sources first. We find the original announcement, regulator decision, register entry or dataset behind the story, and link it in the article. A news report about a news report is not a source.
  2. Every fact and figure checked. Names, dates, numbers and quotes are checked against those sources. Anything we cannot confirm is left out or marked as "not disclosed", and reported figures are attributed to whoever reported them.
  3. Human editor sign-off. A human editor reviews, verifies and approves the article. Nothing is published automatically.
  4. Fixed in the open. If we get something wrong, we correct the article, note the date on it, and add it to our public corrections log.

We report what regulators, companies and researchers have said or published. We do not give medical advice, and clinical or regulatory interpretations are attributed to their source.

How we label content

The label at the top of each article tells you what you are reading:

  • News: reporting on an announcement, decision or event, written by our team from primary sources.
  • Career guide: practical career advice written by our team, such as LinkedIn and CV guides.
  • Contributed: written by a guest author or a company, with their details shown, and reviewed by our editor before publication.
  • Partner content: material connected to a media partnership or event we support. It is labelled at the top and is not independent news.

Independence

We are independently owned and editorially free. Advertising and sponsorship never influence coverage; partner or sponsored content is labelled at the top of the article and is never presented as independent news. We do not accept payment for editorial coverage.

AI assistance

We use AI tools to assist with drafting, data processing and research. Every published article is reviewed, verified and approved by a human editor before publication, and responsibility for accuracy rests with our editorial team.

Corrections

When we get something wrong, we fix it quickly and transparently. Significant corrections are noted on the article itself with the date of amendment. To request a correction, email info@priyalifescience.com or use our contact form - we aim to respond within two business days. Every correction to our data registers and articles is listed in our public corrections log, and how each dataset is built is on the methodology page.

Ownership

Priya Life Science was founded in 2025 by Sreepriya Prasannan, launched its website in 2026 and is operated from Ireland. It is owned and run by its founder and built with and for the community it serves. It is not owned by, or affiliated with, any pharmaceutical company, recruiter or investor group.

Medical & Pharmaceutical Disclaimer

All content, reporting, data, and regulatory information published on Priya Life Science are provided strictly for educational, news, and professional industry intelligence purposes. Information on this website does not constitute medical, diagnostic, therapeutic, legal, or financial advice. Healthcare decisions should always be made in consultation with licensed healthcare professionals.